Back to Atlas
BSemi-durableStandard research/education caution
CMP-0168
Investigational
ARA-290 / Cibinetide
Neuroregenerative / Anti-inflammatory
Neuropathic pain and tissue-repair signaling
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Peptide
- Primary mechanism
- Innate repair receptor modulation
- Primary market use
- Neuropathy
Pharmacology
- Molecular weight (Da)
- ~1258
- Oral bioavailability
- N/A
- Half-life
- ~2 min
- Route tags
- Route-dependent / verify
- Evidence level
- Human clinical
- Clinical status
- Investigational
- Value-for-money score
- 5 / 10
Reported protocol signal
Treatment length: 4-5 weeks SQ: • 1-5 mg daily (Muscle + Brawn)
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Could be A or B depending endpoint